ทั้งนี้ตนมีความหวังว่า หากการวิจัยป

This is a hope that a successful research. The vaccine can be used to prevent AIDS as disease prevention vaccine; But it did not work with people who are infected. " Prof. m.d. u.s pannee said today the country's AIDS prevention vaccine development, Thailand. It works to, but cannot guarantee that it will be successful or not. The vaccine, which the researchers will know whether the vaccine research failure can happen every step and each type of vaccine development research, it takes very long. "However, what are the obstacles of vaccine research, funding to support the ongoing vaccine research. Example of a case of AIDS prevention vaccine research that supported the United States, which funds from their own country, they expect in the future, the Government would clear Thailand's policy and to support the ongoing costs. We invest in the personnel section of the Government will have to find funding sources. " "There is a national vaccine Institute. counts as a good story with a central unit, in a push to boost knowledge of vaccine management. Publication of an integrated knowledge of vaccine coverage of knowledge throughout the development cycle, from the research, policy development, vaccine development, vaccine production and use on the national level, which is one of the key mechanisms that can be linked to the vaccine, driven forward, but because of a complex vaccine research. Therefore, there is only one agency might not be enough. " Prof. m.d. u.s pannee said. While Dr. m.d. to attract city win. Director National Vaccine Institute (public organization), said the vaccine is on the business the. What the developing countries need a vaccine shortage problem faced is, and if there is no vaccination, you have people died in this world more than 15 million visitors per year, and the way to get the vaccine, not directly, but there is a risk of high winds and. ปัจจุบันปริมาณการใช้วัคซีนในประเทศกำลังพัฒนามีมากถึง 88% ของตลาดรวมแต่มูลค่าวัคซีนมีเพียง 12% เนื่องจากส่วนใหญ่เป็นวัคซีนราคาถูก ดังนั้นจึงไม่ดึงดูดใจในแง่การค้า เป็นผลให้การผลิตวัคซีนสำหรับประเทศที่กำลังพัฒนามีทิศทางลดลงอย่างชัดเจน หากบริษัทวัคซีนต่างๆหยุดผลิตปัญหาที่ตามมาคือไทยหรือบางประเทศก็ไม่สามารถสำรองวัคซีนเป็นจำนวนมากได้ และไทยอาจไม่สามารถหาซื้อวัคซีนติดต่อกันทุกปีได้ อีกทั้งแม้ประเทศจีน อินเดีย บอกว่าผลิตวัคซีนได้ในราคาถูก แต่ไทยก็ซื้อในราคาที่แพง เพราะมันเป็นเรื่องของธุรกิจ เมื่อเปรียบเทียบกับอุตสาหกรรมอื่นจะเห็นว่าต้นทุนวัคซีนเพิ่มขึ้นทุกปี ดังนั้นหากเราผลิตวัคซีนได้สำเร็จเราก็จะมีความมั่นคงเรื่องการใช้วัคซีนในประเทศมากขึ้น

We are hopeful that their If the researchers succeed Such vaccines can be used as a vaccine to prevent AIDS in general. Only use not only affect those who are already infected, " Prof. MD. Supannee. Said today the development of a vaccine against AIDS. The result was that in a good way. You can not guarantee that it will succeed or not. The researchers are aware that vaccine. The failure of vaccine research can occur at any stage. Each type of vaccine research, development and takes a very long time , "However, the main obstacle is that vaccine researchers of funding to support continuing research on the vaccine. The case of AIDS vaccine research was supported by grants from the United States. This self-government in Thailand is expected to have a clear policy and to support ongoing capital as well. Our investment in terms of personnel, the government will have to find sources of funding ", "The National Vaccine Institute is a great story. A central agency to be a push for the management of knowledge on vaccines. The dissemination of knowledge on integrated vaccine. Comprehensive knowledge of the vaccine development cycle. Since policy development Research The production and use of vaccines in the state. This is one important mechanism that can be linked to drive forward work on the vaccine. However, because the vaccine is a complex research. Therefore, there is only a single agency may not be enough, "Prof. MD. Supannee said while Dr. MD., attracting the city won, director of the National Vaccine. (ITD), said that with the vaccine business infrastructures. The developing countries will face a shortage of vaccine. And if the vaccine would have died in this world more than 15 million people per year, and the way to get the vaccine is not direct. However, a maze and a higher risk of current vaccination in developing countries with up to 88% of the total market, but the vaccine is only 12%, due mainly to cheaper vaccines. So it is not attractive in terms of trade. As a result, the production of vaccines for developing countries has been reduced significantly direction. If companies stop producing the vaccine in Thailand or the issue is that some countries can not back up a large number of vaccines. And Thailand may not be able to buy the vaccine consecutive years. Moreover, although China, India, said that vaccine manufacturers were cheaper. But Thailand was purchased at affordable prices. It's all about business Compared to other industries that would increase the cost of the vaccine every year. If we succeed, we will have a vaccine stability of the vaccine in the country.

However, their hope that if the success. The vaccine can be used for preventing AIDS vaccines against diseases like general. Will only work with those already infected. "

Prof. Dr.Radiant, said today in the development of an AIDS vaccine development, he has worked the way good. But also can not be guaranteed to succeed or not. The researchers in the vaccine will know thatResearch and vaccine development each kind takes a very long!
."However, what obstacles of important research in the field of finance support research in vaccine is a vaccine that continuously. Case of AIDS vaccine research supported the capital from the United States.